Search

Your search keyword '"Bloomfield, Clara D."' showing total 1,756 results

Search Constraints

Start Over You searched for: Author "Bloomfield, Clara D." Remove constraint Author: "Bloomfield, Clara D."
1,756 results on '"Bloomfield, Clara D."'

Search Results

1. Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes

2. Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial

3. Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

4. Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq

5. Core‐binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I‐CBFit)

7. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial

8. Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

9. Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

10. Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia

12. Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

13. Clinical and functional significance of circular RNAs in cytogenetically normal AML

14. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.

15. Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665

16. Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years

18. A precision medicine classification for treatment of acute myeloid leukemia in older patients

20. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

21. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

23. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

25. Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically

26. Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA

27. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

29. Correction: Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq

30. Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia

31. A Pilot Study of High-Throughput, Sequence-Based Mutational Profiling of Primary Human Acute Myeloid Leukemia Cell Genomes

32. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

33. Publisher Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia

36. The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia

40. Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies

41. Data from Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia

42. Data from Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia

43. Supplementary Table S2 from Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia

44. Supplementary Methods; Supplementary Tables S1, S3; and Supplementary Figures S1-S2 from Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia

45. Supplementary Tables 1 - 4, Figures 1 - 6 from Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia

46. Supplementary Materials from Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality

47. Supplementary Table S4 from Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia

48. Data from Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality

49. Supplementary Data from Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia

50. Supplementary Data from EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia

Catalog

Books, media, physical & digital resources